Pharma Deals Review, Vol 2004, No 44 (2004)

Font Size:  Small  Medium  Large

AstraZeneca and Array BioPharma Sign Oncology Agreement

Business Review Editor

Abstract


AstraZeneca signed a licensing and collaborative agreement with Array BioPharma concerning an MEK anticancer research program. The program will include the development of Array’s lead product, ARRY-142886.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.